Hans‐Theodor Eich

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Volker Diehl et al. · Journal of Clinical Oncology · 2011 · 190 citations

Medicine, Oncology, Radiation Oncology +11

A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly)

Veronika Ballová, Jens Ulrich Rüffer, Heinz Haverkamp et al. · Annals of Oncology · 2004 · 159 citations

Medicine, Geriatric Medicine, Geriatrics +3

Assessment of Tumor Size Reduction Improves Outcome Prediction of Positron Emission Tomography/Computed Tomography After Chemotherapy in Advanced-Stage Hodgkin Lymphoma

Carsten Kobe, Georg Kuhnert, Deniz Kahraman et al. · Journal of Clinical Oncology · 2014 · 64 citations

Medicine, Nuclear Medicine, Oncology +17

Role of [18F]-fluoro-2-deoxy-<scp>d</scp>-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone

Jana Marková, Deniz Kahraman, Carsten Kobe et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 59 citations

Medicine, Nuclear Medicine, Oncology +15

Rituximab With Involved Field Irradiation for Early‐stage Nodal Follicular Lymphoma

Klaus Herfarth, Peter Borchmann, Sven Schnaidt et al. · HemaSphere · 2018 · 54 citations · Full text

Medicine, Oncology, Pharmacotherapy +17